Recipharm is equipped to take on your semi-solid development and manufacturing project at one of four sites.
General APIs, as well as corticosteroids and controlled drugs, are handled within Recipharm's semi-solid dose manufacturing facilities.
Recipharm manufactures creams, ointments, gels, emulsions, aerosols and suppositories with conventional technology, including mixing with heating and vacuum. A unique topical patch manufacturing system is available for sustained drug release. Other products are filled in aluminum tubes, plastic tubes with long or short necks, syringes and aluminum cans, while suppositories are delivered in PVC or aluminum blisters. Creams can be processed using sterile manufacturing technology with aseptic filling into aluminum tubes. Separate terminal sterilisation is offered. We also offer product development services of topical and transdermal formulations.